Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Basic Science Investigation

  • <sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice
    You have access
    89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice
    Linda N. Broer, Daan G. Knapen, Frans V. Suurs, Ingrid Moen, Danique Giesen, Stijn J.H. Waaijer, Baard Indrevoll, Christine Ellingsen, Alexander Kristian, Alan S. Cuthbertson, Derk-Jan A. de Groot, Patricia E. Cole, Elisabeth G.E. de Vries, Urs B. Hagemann and Marjolijn N. Lub-de Hooge
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1715-1721; DOI: https://doi.org/10.2967/jnumed.121.263079
  • Synthesis and Preclinical Evaluation of <sup>18</sup>F-Labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
    You have access
    Synthesis and Preclinical Evaluation of 18F-Labeled Ketoprofen Methyl Esters for Cyclooxygenase-1 Imaging in Neuroinflammation
    Miho Shukuri, Aya Mawatari, Shuhei Takatani, Tsuyoshi Tahara, Michiko Inoue, Wakiko Arakaki, Masahiro Ohno, Hisashi Doi and Hirotaka Onoe
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1761-1767; DOI: https://doi.org/10.2967/jnumed.121.263713
  • A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After <sup>177</sup>Lu-Peptide Receptor Radionuclide Therapy
    You have access
    A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After 177Lu-Peptide Receptor Radionuclide Therapy
    Yuni K. Dewaraja, David M. Mirando, Avery B. Peterson, Jeremy Niedbala, John D. Millet, Justin K. Mikell, Kirk A. Frey, Ka Kit Wong, Scott J. Wilderman and Aaron S. Nelson
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1665-1672; DOI: https://doi.org/10.2967/jnumed.121.263738
  • CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
    You have access
    CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
    Andrew G. Kunihiro, Samantha M. Sarrett, Kristin J. Lastwika, Joell L. Solan, Tatyana Pisarenko, Outi Keinänen, Cindy Rodriguez, Lydia R. Taverne, Annette L. Fitzpatrick, Christopher I. Li, A. McGarry Houghton, Brian M. Zeglis and Paul D. Lampe
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1701-1707; DOI: https://doi.org/10.2967/jnumed.121.263511
  • Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
    You have access
    Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
    Zhen Yang, Feng Li, Yuqian Huang, Na Yin, Junjun Chu, Ying Ma, Roderic I. Pettigrew, Dale J. Hamilton, Diego R. Martin and Zheng Li
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1708-1714; DOI: https://doi.org/10.2967/jnumed.121.263151
  • Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging
    Open Access
    Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging
    Matthew G. Spangler-Bickell, Samuel A. Hurley, Ali Pirasteh, Scott B. Perlman, Timothy Deller and Alan B. McMillan
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1604-1610; DOI: https://doi.org/10.2967/jnumed.121.263309
  • Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
    You have access
    Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
    Katherine L. Lucot, Marc Y. Stevens, T. Adam Bonham, E. Carmen Azevedo, Aisling M. Chaney, Ebony D. Webber, Poorva Jain, Jessica L. Klockow, Isaac M. Jackson, Mackenzie L. Carlson, Edward E. Graves, Thomas J. Montine and Michelle L. James
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1570-1578; DOI: https://doi.org/10.2967/jnumed.121.263039
  • <sup>223</sup>Ra Induces Transient Functional Bone Marrow Toxicity
    You have access
    223Ra Induces Transient Functional Bone Marrow Toxicity
    Maria Parlani, Francesco Boccalatte, Anna Yeaton, Feng Wang, Jianhua Zhang, Iannis Aifantis and Eleonora Dondossola
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1544-1550; DOI: https://doi.org/10.2967/jnumed.121.263310
  • Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study
    You have access
    Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study
    Doris Leithner, Heiko Schöder, Alexander Haug, H. Alberto Vargas, Peter Gibbs, Ida Häggström, Ivo Rausch, Michael Weber, Anton S. Becker, Jazmin Schwartz and Marius E. Mayerhoefer
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1611-1616; DOI: https://doi.org/10.2967/jnumed.121.263102
  • Synthesis and Preclinical Evaluation of <sup>177</sup>Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
    Open Access
    Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
    Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco de Rose, Calogero D’Alessandria, Wolfgang Weber and Hans-Jürgen Wester
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1489-1495; DOI: https://doi.org/10.2967/jnumed.121.263371

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 39
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire